Our signature product is Naloxone Exchange, and we expect a launch date in 2019. 

Our future pipeline focuses on technology that reduces drug overdose through connectivity, and expanding access to life saving resources. Check back, for updates, and please feel free to CONTACT US!

- Team Fiduscript.